Trial to Investigate the in Silico Optimization of Insulin Treatments

Status unconfirmed · Not applicable

Conditions studied: Coronary Artery Bypass

In brief

The primary objective of this study is to assess the performance of an in silico designed alternative protocol for control of stress hyperglycemia of inpatients treated for Coronary Artery Bypass Graft (CABG) or valve replacement surgery in the University of Virginia cardiothoracic ICU.

Key facts

Study ID

NCT03895138

Run by

University of Virginia

People needed

35

Starts

2018-03-19

Expected to finish

2019-04-30

Last updated by the study team

2019-03-29

Who can join

Age: 40 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients admitted for CABG and/or open heart valve surgery
• Must have a 0.05 initial multiplier setting for the Glucommander based on the manufacturers recommendations
• Age of 40-75, inclusive

You may not qualify if…

• History of severe hypoglycemia within six months of hospital admission
• Currently undergoing dialysis or renal replacement therapy
• Women of childbearing potential
• Patients with endocarditis needing valve replacement
• Participation in another clinical trial at the time of screening.

Where it is running

• University of Vrginia — Charlottesville, Virginia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.